The Patent Finder

Shin Nippon Biomedical Laboratories, Ltd.

23 patents currently held · Updated Nov 20, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Oct 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 21, 2026
    The maintenance fee for Test substance administration system for animal experiment (US 10,293,123) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
  • 1 fee due Feb 11, 2027
    The maintenance fee for Intranasal pharmaceutical compositions with improved pharmacokinetics (US 9,101,539) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Intranasal Delivery Devices (US 11,744,967) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 1 fee due May 5, 2027
    The maintenance fee for Methods and compositions for intranasal delivery (US 10,463,723) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Pharmaceutical Compositions (US 11,872,314) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
  • 1 fee due Oct 26, 2027
    The maintenance fee for Primate Restraint Device (US 9,320,582) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,673,360Compositions that enable rapid-acting and highly absorptive intranasal administration
In force
 · USPTO record
In forceUSPTO record
US 10,195,139Preparation for transnasal application
In force
 · USPTO record
In forceUSPTO record
US 10,293,123Test substance administration system for animal experiment
In force
 · USPTO record
In forceUSPTO record
US 8,337,817Preparation for transnasal application
In force
 · USPTO record
In forceUSPTO record
US 9,101,539Intranasal pharmaceutical compositions with improved pharmacokinetics
In force
 · USPTO record
In forceUSPTO record
US 9,320,582Primate Restraint Device
In force
 · High confidence
In forceHigh confidence
US 8,899,184Primate Restraint Device
In force
 · High confidence
In forceHigh confidence
US 8,827,946Intranasal granisetron and nasal applicator
In force
 · USPTO record
In forceUSPTO record
US 10,463,723Methods and compositions for intranasal delivery
In force
 · USPTO record
In forceUSPTO record
US 9,363,979Primate Restraint Device
In force
 · High confidence
In forceHigh confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
Also on record, not counted in the 23: 5 patents in force now held by others · 9 lapsed for an unpaid fee · 4 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited